Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Norris Medicines Ltd.

Norris Medicines

0.00

0.00 (0.00)%

NSE

BSE

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

1. Vimal Shah
Executive Director
2. A Vadivel
Non Executive Independent Director
3. Praveen Bafna
Non Executive Director
4. Sathya Venkatachalam
Non Executive Independent Director
5. Priyanka Lohiya
Company Secretary

Contact Information

Company Address

Plot No. 801 / P, G I D C, Industrial Estate
Ankleshwar, Gujarat - 393002
www.norrispharma.com
secretarial@norrispharma.com

Registrar

Purva Shareregistry (India) Pvt Ltd
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg
Phone: +91 22 4134 3255/ +91 22 4134 3256
Email: support@purvashare.com
Website: www.purvashare.com

Company Profile

Norris Medicines is one of the leading Indian manufacturers of Injections and Medicinal formulations. More than two decades of our existence has made us a significant force in production, research and manufacture of medical preparations. Norris in India is a widely recognized name in the manufacturing and export of the best quality medicines and injections. The company is into this business since 1990 and serving human being with our world class products.

Business area of the company

The business area of the company is manufacturing of Injections and Medicinal formulations.

Products of company

The products of the company covers wide range of modern medicinal field such as Antibiotics, Anti Inflammatory, Dermatology, Nutrition, Gastro, Anti malarial, Dental, Diabetic & Cardiac.

Milestones

  • 1992: Launch of Ethical Division and conversion of company into Public Limited company.
  • 1994: WHO cGMP Certificate.
  • 1995: Major Expansions.
  • 1996: Started exporting to European, Middle East, Far East and African Countries.
  • 2006: Launching of Diabetic & Cardiac products.
  • 2007: Launching of Dental product range.
  • 2012: Launching of New Molecule Tolperisone with Paracetamol tablet.
  • 2013: Extension in Anti malarial range with Artemether Lumefantrine tablet & dry syrup.
Enrich money logo